Wall Street RegretsThe regret calculator.

What if you'd held ALNY?

A $1,000 investment in Alnylam Pharmaceuticals, Inc. (ALNY) at the month-end close of 2004-06 would be worth $32,091 at the close of 2026-08 — +3109.1% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $6,756.

$1,000 since 2004$32,091Total return+3109.1%Multiple32.1×CAGR+16.9%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$32,091Gain+$31,091 (+3109.1%)Multiple32.1×CAGR+16.9%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2004$32,0912005$32,4782006$18,2142007$11,3372008$8,3432009$9,8102010$13,7692011$24,6052012$29,7682013$13,2942014$3,7732015$2,5012016$2,5772017$6,4802018$1,9102019$3,3282020$2,1072021$1,8672022$1,4312023$1,0212024$1,2672025$1,0312026$610

    Every year, $1,000 from 2004

    YearValue of $1,000Year return
    2004$1,000
    2005$1,783+78.3%
    2006$2,865+60.7%
    2007$3,893+35.9%
    2008$3,311-15.0%
    2009$2,359-28.8%
    2010$1,320-44.0%
    2011$1,091-17.3%
    2012$2,443+123.9%
    2013$8,608+252.3%
    2014$12,985+50.9%
    2015$12,602-2.9%
    2016$5,012-60.2%
    2017$17,008+239.3%
    2018$9,760-42.6%
    2019$15,418+58.0%
    2020$17,399+12.9%
    2021$22,701+30.5%
    2022$31,814+40.1%
    2023$25,624-19.5%
    2024$31,501+22.9%
    2025$53,233+69.0%
    2026$32,478-39.0%

    Best and worst month-end to buy

    The best single month-end close to have bought ALNY was 2004-07 ($5.15): $1,000 then is $47,109 today. The worst was 2025-10 ($456): $1,000 then is $532.

    FAQ

    What would $1,000 in ALNY be worth today?

    A $1,000 investment in Alnylam Pharmaceuticals, Inc. (ALNY) at the start of 2004 would be worth about $32,091 today, a total return of +3109.1%. Dividends are reinvested in these figures.

    What were the best and worst years for ALNY?

    Alnylam Pharmaceuticals, Inc. (ALNY)'s strongest calendar year since 2004 was 2013, a +252.3% return — $1,000 held through that year became about $3,523 by year-end. Its weakest year was 2016, at -60.2%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in ALNY have grown?

    Investing $100 at the end of every month since 2004-06 would have grown to about $235,063 on $26,700 invested.

    Did ALNY beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $6,756. ALNY beat the S&P 500 by +375.0% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Alnylam Pharmaceuticals, Inc. (ALNY) historical total-return data from 2004-06 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.